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INTRODUCTION
In the past five years, the psychological literature
has become awakened to the importance of chemical coding
in certain brain structures. Largely due to the work of
Grossman and others, it has now become generally acceptable
to talk about certain modes of behavior as being controlled
by neural systems that are chemically distinct (i.e.,
systems that contain the same specific neural transmitter
substance )
.
Specifically, two types of neurochemical systems have
been investigated principally because these systems are
known to function in the peripheral nervous system. The
chemical substances which act to mediate these two systems
are acetylcholine (ACH) and the catecholamines. The role
of acetylcholine in the transmission of nervous impulses
in the peripheral nervous system has been extensively
documented. Likewise, pharmacologists have studied the
role of the various catecholamines in depth and have left
little doubt that these chemicals also act as chemical
transmitters at the terminals of the peripheral
sympathetic nervous system (Schildkraut and Kety, 1967)
•
Whether or not the above two chemicals act in a
similar manner in the central nervous system is still in
doubt. No conclusive neurophysiological evidence has yet
been produced that points to any single chemical substance
as being a central transmitter. There is some fragmentary
evidence that suggests that several chemical substances
(including acetylcholine and the catecholamines) may act
as central transmitters. These data are not as yet
conclusive and until specific evidence (e.g., discovery of
naturally occurring stores of ACH or norepinephrine in
presynaptic endings, etc.) is obtained on the existence of
central transmitters, caution must be exercised in proposing
such systems.
With the above consideration in mind, psychologists
and pharmacologists have nevertheless found it advantageous
to assume that there are naturally occurring chemical
transmitters in the central nervous system. These chemicals
are amenable to change by the introduction of certain drugs
with known pharmacological properties and thus the levels
of certain brain amines thought to be central transmitters
are open to experimental manipulation. These manipulations
can then be correlated with observed behavioral changes
in an attempt to infer what kind of systems in the CNS
control specific behavioral changes. In other words,
psychologists use drugs with known properties as tools in
the study of processes that may control the behavior of
the normal animal. This type of inferential analysis
necessarily has its drawbacks when one is dealing with the
varied and complex processes that must go on in the CNS.
These drawbacks, however, are somewhat offset by the
relatively precise and controlled behavioral measures
that the psychologist can devise to test behavioral deficits
that are correlated with the introduction of certain drugs.
The psychologist, therefore, is able to add certain
inferential data that are helpful to other disciplines in
their search for more direct evidence on the role of chemical
modulation in the CNS.
With these basic considerations in mind, the evidence
for cholinergic and adrenergic mediation of behavior will
be presented.
Carlton (1963) proposed a mechanism for the control of
behavior which assumed that behavioral responses were a
result of the interplay of two functionally independent
neurochemical systems in the brain. One system was assumed
to be cholinergic and to function to inhibit unrewarded
responses. The other system, according to Carlton, was
adrenergic and increased activity to all responses.
According to this mechanism, learning could be considered
a function of cholinergic inhibition of unrewarded response
systems and the ensuing dominance of the uninhibited
adrenergic excitatory control system that is rewarded.
In other words, all those responses that are unrewarded
are inhibited by a cholinergic system thus allowing the
one adrenergic system (rewarded response) that is not
inhibited to become dominant.
The evidence that Carlton (1963) cites to support his
thesis covers a wide range of behavioral situations. The
first assumption of this mechanism - that there are two
functionally opposed chemical systems present in the CNS,
one which increases behavioral responses and the other which
inhibits them - has been tested. Elevations of cholinergic
activity with eserine have been shown to produce a marked
inhibition of avoidance responding similar to that produced
by reserpine or chlorpromazine (Pfeiffer and Jenney, 1957).
Pfeiffer and Jenney also obtained such results with
pilocarpine and arecoline, drugs known to mimic the effects
of ACH (Goodman and Gilman, 1955). This evidence thus
lends support to Carlton's mechanism by showing decreased
behavioral responding to either an increase in cholinergic
activity or a decrease in adrenergic activity. This would
be expected if the two systems were antagonistic.
Furthermore, Pfeiffer and Jenney (1957) have provided
data that strongly suggest that these effects were due
to an action on the central, rather than the peripheral
nervous system.
The excitatory effects of increased adrenergic activity
has been documented by Scheckel and Boff (1966). They
reported increased rates of responding on Sidman avoidance
schedules to injections of tetrabenazine and iproniazid.
Tetrabenazine releases the bound stores of norepinephrine
within the cell which then diffuse out of the cell and
apparently increase nervous activity via their role as
central transmitters. The norepinephrine itself is not
metabolized by MAO due to the introduction of iproniazid
which is a MAO inhibitor. In their paper, Scheckel and
Boff (1966) report several other experiments which vary the
level of brain norepinephrine in the rat with the same
results. If norepinephrine is released externally (i.e.,
not allowed to be metabolized by MAO) behavioral measures
(i.e., Sidman) increase while if levels of norepinephrine
are decreased by drugs such as reserpine, behavioral
measures show a decline in response rate.
Other investigators have noted a relationship between
excitatory adrenergic activity and certain behavioral
situations which give rise to emotional states. Mason,
Mangan, Brady, Conrad, and Rioch (1961) have found, in
the rhesus monkey, that increases in blood levels of
epinephrine occurred in situations which combined
uncertainty or unpredictability with the threat of noxious
stimuli and anticipation of the need for coping behavior.
Release of norepinephrine without concurrent elevation of
the epinephrine level occurred when the conditions
associated with administration of the noxious stimuli
were familiar, unambiguous, and predictable. In other
words, adrenergic activity seems not only to cause more
behavioral response activity but, in turn, seems to be
correlated with fear-like emotional states.
Returning to Carlton's (1963) hypothesis concerning
a cholinergic inhibitory system, it will be remembered
that this system effects non-reinforced responses only.
Pfeiffer and Jenney's (1957) work pointed to the existance
of a cholinergic system which antagonized an adrenergic
system leading to fewer behavioral responses. Going one
step further, Hearst (1959) also has reported evidence
that indicates that this cholinergic system acts to
inhibit non-reinforced responses. In this study, animals
were trained to "wait", not respond, for a given period,
after which one of two auditory stimuli was presented.
Reinforcement was delivered to the animal only if it
pressed a particular lever of the two available when one
stimulus was on and pressed the other when the other stimulus
was on.
The animals normally responded appropriately to the
levers during stimulus periods and emitted few responses
between them. When given scopolamine (an anticholinergic
drug), however, they emitted many responses between periods
and tended to perseverate in their responding to one
lever, regardless of which stimulus was on. The animals
were subsequently given a series of extinction sessions,
during which responding declined. The animals were
continued on extinction but were then given injections of
scopolamine before each session. Hearst found that (a)
levels of responding returned to those obtained under the
drug before extinction, (b) this behavior was also
characterized by a tendency to perseverate and to respond
between stimulus periods, and (c) continued extinction
under scopolamine (for thousands of non-reinforced responses)
7failed to result in a decline in performance. He also
reported that when the scopolamine injections were
discontinued, performance dropped to the low levels that
had been obtained before scopolamine injections were begun.
Thus, it would seem that attenuation of cholinergic
activation does, indeed, release responses that are normally
inhibited due to non-reinforcement.
Other studies bear on the relationship between
non-reward and cholinergic activity. Carlton (1961)
showed that amphetamine (a drug which mimics the effects
of norepinephrine), scopolamine, and atropine increased
the number of errors made during the acquisition of an
alternating two bar instrumental situation. These effects
can be related to the increased probability of intrusion
of incorrect responses due to an increase in activation
with amphetamine, on the one hand, and to an attentuation
of the usual effects of non-reinforcement with the
anticholinergics on the other.
Rather similar effects to those cited above were also
reported by Whitehouse (1959) who used the traditional T
maze. It is reasonable to suppose that learning to make
a correct "choice" in a T maze involves, to some extent,
the extinction of the tendency to make the wrong one. In
the study by Whitehouse, it was found that reduction in
cholinergic activity with atropine significantly decreased
the rate at which rats learned discrimination problems in
the maze. Furthermore, whitehouse (1967) has also reported
8that atropine produces a significant decrement in acquisition
over and above the decrement produced by the addition of
irrelevant cues in a T maze. Additionally, the decrement
produced by atropine was dose related. Whitehouse thus
concludes that this experiment lends support to Carlton's
(I963) view that a cholinergic system in the brain is
involved with the extinction of non-reinforced responses,
since it can be assumed that responses to irrelevant cues
required extinction and that the increase in number of cue
alternatives of which only one set was relevant placed
greater demands on the cholinergic system.
Krech, Rosenzweig and Bennett (i960) have added more
interesting data that tend to support Carlton's (1963)
mechanism of an inhibitory cholinergic system that mediates
unrewarded responses. They report that animals exposed
to more complex environments show a different cortical-
subcortical cholinesterase (ChE) ratio than animals who
have not been so exposed. Specifically, they note that
the more complex the environment, the lower the cortical-
subcortical ratio of cholinesterase activity. Controls
for body weight, strain and nutritional factors were used
as well as controls for change due to handling and locomotor
activity. These authors concluded that this evidence
demonstrates a measurable and consistent change in the
patterning of ChE in the rat brain as a function of
environmental stimulation.
9To clarify how this data lends support to Carlton's
thesis one can refer to an earlier study by Krech, Rosenzweig
and Bennett (1956). In this study, hooded rats were tested
in the Krech Hypothesis Apparatus under the progressively
soluble training procedure. After testing, the animals
were sacrificed and determinations were made of their level
of cholinesterase activity in the visual and somesthetic
areas of the cerebral cortex. An analysis of the behavioral
and chemical data suggested that the behavioral differences
between animals high and low in ChE activity level indicate
differential ability to shift the dimension of discrimination,
such that a high ChE level is associated with an ability
to maintain a probabilistic response pattern, while a
low ChE level is associated with a more thorough commitment
to the dominant stimulus (Krech et al., 1956). These two
studies supply data that suggest that brain levels of ChE
are related to environmental stimulation. Consequently,
stimuli are able to modify chemical concentrations in the
brain which, in turn, can modify electrical transmission.
Thus, the link between external experience and brain
modification is made. Furthermore, this change in
chemical concentrations seems to be related to behavioral
response patterns in that the more ChE available the more
able an animal is to inhibit a response to the dominant
stimulus in favor of a more probabilistic pattern.
Therefore, as we will see below, higher concentrations
of ChE lead to more activity in cholinergic systems which
10
allows the animal to inhibit responses to dominant stimuli,
thus allowing for shifts in the dimension of discrimination
which leads finally to a more probabilistic response
pattern based on reward. Cn summary, high ChE level
insure an active cholinergic system which inhibits
unrewarded responses, thus prohibiting any dominant
stimulus to determine behavior. Behavior is then determined
solely by the reward conl,:l n^ene i or.
.
More conclusive evidence for the above statements
was provided by Russel, Watson and Frankenhaeuser (1961).
They reported thai reduced brain ChE activity was
associated with differential effects on the behavior
(i.e., speed of conditioning was not altered significantly,
whereas speed of extinction was so effected). Specifically,
high ChE levels were associated with fast extinction and
vice verr.'i. In discussing their findings, Russel et al.
(396]) noted thai Chi'! ,'iotiv.ity level provide:; '1 m< •;i.:'.ure
of the readiness of nerve impulse transmission in the
CNS and that the relative ease of nerve impulse
transmission requires the extinction of old behavior
patterns and the formation of new ones. Under such
circumstances, speed of extinction might well be the
pacemaker step in the series of adaptive behavior changes.
The above experiment tends to support the conclusion that
this pacemaker step, at least under certain circumstances, .
is related to brain ChE activity in such a way that high
11
ChE activity is associated with more rapid extinction.
This finding has much in common with the suggestions
of Krech et al. (1956) mentioned above. Specifically,
high cholinergic activity leads to faster extinction and
extinction is simply the inhibition of an unrewarded
response. Therefore, the above series of studies suggest
that ChE levels can be modified by experience and that
higher levels tend to allow the animal to inhibit responses
that are unrewarded even if they are responses to dominant
stimuli. High levels of ChE thus lead to faster extinction
which Is the first step in the behavioral change implied
in learning.
Let us now briefly review the essential concepts
outlined thus far in this presentation. Carlton (1963)
has suggested that there are two mutually antagonistic
neurochemical systems In the brain. One is excitatory,
adrenergic in nature, and coupled to reward. The other
is inhibitory, cholinergic, and controls responses that
are unrewarded. Evidence has been cited showing that
response levels can be manipulated using this model as
a reference. Decreased cholinergic or increased
adrenergic activity leads to more response activity
(Hearst, 1959; Scheckel and Boff, 1966). Increases in
cholinergic activity or decreases in adrenergic activity
leads to less behavioral activity (Pfeiffer and Jenney,
1957; Scheckel and Boff, 1966). Furthermore, adrenergic
12
activity can be increased by exposure to emotional states
that can be described as fear or conflict situations
(Mason et al.
, 1961)
.
Finally, evidence was reviewed that supported Carlton's
hypothesis that the cholinergic system acts to inhibit
unrewarded responses. Hearst (1959) reported that a
reduction in cholinergic activity (via the introduction
of scopolamine) blocked extinction. Carlton (1961) showed
that amphetamine, scopolamine, and atropine increased the
0
number of errors made during the acquisition of an
instrumental response. Krech et al. (i960) showed that
increased cholinergic activity via increased ChE level
led to inhibition of responses to dominant stimuli leading
to a more varied response pattern. Finally, Russel et al.
(1961) demonstrated that decreased ChE levels lead to
slower extinction and thus less inhibition to unrewarded
responses. In summary, then, there is considerable
support for the idea that there are two mutually
antagonistic systems, one which adrenergically mediates
responses followed by reward, and one which cholinergically
inhibits responses followed by nonreward.
Since the publication of Carlton's paper in 1963, there
has been reported in the literature several instances
where anticholinergic drugs have failed to affect
performance. If an active cholinergic inhibitory system
were located in the brain, the introduction of such drugs
would be expected to adversely effect the performance of
13
a learned response. Addressing himself to these inconsistent
findings, Gerbrandt (1965) has proposed a modification of
Carlton's original hypothesis. Specifically, Gerbrandt
(I965) proposes a descriptive model which assumes that
control of behavioral responses is a function of discrete
brain systems, mutually inhibitory in their effects, which
function to release highly stable responses or to increase
the stability of a behavioral response by inhibiting
competing responses of higher stability. The author
further proposes that these systems can be biased by
cholinergic stimulation and adrenergic blockage and vice
versa. This model thus assumes that such stable responses
as active avoidance are controlled by a system that releases
this stable response. Unstable responses such as passive
avoidance are acquired by active inhibition of more stable
competing responses by another system. Furthermore, when
one system is acting (the releasing system analagous to
Carlton's adrenergic system), the other (inhibitory
system analagous to Carlton's cholinergic system) is
inactive. Under this model learning is a function of
inhibiting competing responses (by a cholinergic system)
in the early phase of learning (acquisition) and the later
release of a stable response by the other adrenergic
system during the performance phase. Somewhere during
the latter stages of acquisition the inhibitory system
phases out and the releasing system phases in.
Evidence for this hypothesis is extensive and varied.
14
It has been reported that crystaline implants of cholinergic,
but not adrenergic, stimulants will interfere with
performance on a CAR when these implants are placed in the
medial septal area (Grossman, 1964). Also, Meyers, Roberts,
Riciputi, and Domino (1964) have found that cholinergic
blocking drugs (scopolamine and atropine) disrupt only
the acquisition and not the retention of a CAR. On the
other hand, chlorpromazine (an adrenergic blocker) blocked
performance of a CAR (Chalmers and Erickson, 1964).
Longo (1966) reported that atropine and scopolamine when
administered during the period of formation of the
avoidance reflex caused notable alterations in the response,
while they were inactive in fully trained animals. Finally,
Meyers (1965) reported that scopolamine disrupted the
acquisition but not the performance of an active avoidance
task while it adversely effected both the acquisition and
the performance of a passive avoidance task. This would
be expected if Gerbrandt is correct in postulating an
inhibitory cholinergic system that phases out after
acquisition of a stable response (active avoidance) but
does not phase out in the acquisition of an unstable
response (passive avoidance). The general implication of
the above studies is that there is a phasing out of a
cholinergic system during acquisition and a phasing in
of an adrenergic control system during the performance
of a learned response.
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In summary, before the Maler paradigm is described,
it seems possible to combine the two above mechanisms
proposed by Carlton (1963) and Gerbrandt (1965) into a
single model that will prove useful in exp] alning a wide
range Of behavior. Ono can nr. mime, an Carl Ion did, tha.L
caoh rosponso has an cxH LaLory adrono ry.l r r,y:;U>m rola.Lod
to it. The s L ran^Lh of Lh 1 s sysLom in rolaLion (.0 the?
strength (or stability) of other competing response systems
dctrnnlncj the probability of this response occurring.
Furthermore, every response has a cholinergic inhibitory
system associated w.i Lh ii which is activated when fchfl
ro S port so Jr. pun 1 shod . Tho ro Toro , Lho I on r\\ 1 n/-r
,
o [' any
rosponso Jr. n Vuno I i on of I, ho I o vo 1 of 1,1 10 o xo :1 La Lo ry
ad r< an ( ry
(
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and Lho oonsoquon L rvducL.lon of ox o J La Lory r.y r. Loins ro I aLod
wJ Lh un n? wardod or' pun I shod n\;])ori;u\*; . As in Go rb rand L 1 s
(
'] ()() { ) ) mod( * I y ono won ] d havo Lo pos Lu 1 a.Lo Lw< > phn sos
.
First, during the early pharos of acquisition many
ror. pons or. a. ro In Lho an J nia 1 1 r. "hah I L h I o r.a ro hy " . In
Lor. L i n// Lh o now s J 1/ua L 1 on , Lh* 1 an 1 ma 1 makos many va r 1 od
responses. Usually only one or two responses are
rowa rdod and Lho oLh o rs aro o I Lho r pun I shod or un ro wa rdod .
Tho rowa, rdod rosponso sy s L orris would bo onh anood (due Lo
food bark from Lho roward ) and Lhur. Lhor.o sys Loins wmild
becomo more eXCited i Tho non-rnwardnd r.yr.Lomr. would sLIll
be rather active and so to insure that the rewarded
<;y s L< ans boo arm : dom.I nan L and roward I r. ob La, i nod , Lho
cholinergic Inhibitory systems would become active as a
consequence of non-reward. They would lower the excitatory
level of the unrewarded systems and so only the rewarded
response would become dominant. Once this dominance Is
established, Gerbrandt's second phase would come into
being. The inhibitory cholinergic systems would phase out
and the dominant excitatory system is "released" to
control behavior.
The Maier Paradigm
The Maier paradigm used in behavior fixations is based
on the two-choice discrimination procedure using the
Lashley jumping stand. The animal is placed on an
electrified grid and allowed to jump to either of two
closed doors (one is dark and the other is illuminated
by a 23 watt bulb). The animal must make a jumping response
within 30 seconds of being placed on the grid or else
a shock comes on and forces a response. In the first
phase the two-choice problem is insoluble - ha] 1* Lhe
responses to the dark and bright windows are punished
by locking the windows and allowing the animal to drop
four feet into a net, and the other half of the responses
to either window are rewarded. The reward is applied to
each window in a random sequence. One other motivational
aspect is present in the Maier paradigm in that the rats
are 23 hours food deprived and food is available behind
the doors on a platform. Whenever the animals choose
17
an unlocked door, they are allowed to eat. This first
insoluble phase goes on for 160 trials - 10 trials a day.
The behavioral result is usually a stereotyped response
to a position (i.e., the animal always jumps to the left
or right window). In the second phase, the problem is
made soluble. A position-stereotyped animal in this stage
is usually given a non-spatial cue (dark) as the correct
response. Therefore, whenever the animal jumps to the
dark it is rewarded, and the dark window is randomly
switched from left to right for 200 trials - 10 trials
a day. In a typical experiment, 15 to 20$ of the animals
solve in this 200 trial period while the rest maintain
their position stereotype (fixation), always jumping
to the right or left. Increasing the testing period over
200 trials rarely leads to any more solutions. There is,
however, ample evidence that fixated animals do
discriminate between the rewarding and punishing aspects
of the soluble problem, in that abortive jumps are fewer
and latencies are typically shorter to the correct stimulus
than to the incorrect. In other words, at the end of the
soluble problem, the fixated rats typically are jumping
more quickly when the dark (rewarded) window appears on
their fixated side than when the bright (punished) window
appears. It can therefore be assumed that the animal has
made the association between reward and punishment and
the two stimuli presented (Feldman and Green, 1967).
The question that readily comes to mind is why the
18
animal persists in making a response (i.e., position
fixation) that to the experimenter is less than desirable.
The animal can receive 100$ reward and no punishment if
the correct response is made. In spite of this, the animal
continues his fixated response pattern even after his
latencies of jumping show that the rat expects punishment
to the bright and reward to the dark window.
With this question in mind, let us now present a
model based on the previously reviewed literature above
that will attempt to clarify the results obtained in
experiments using the Maier paradigm.
Statement of the Model
First of all, the assumptions of the model are taken
directly from the evidence presented by Carlton (1963)
and Gerbrandt (1965) reviewed above. They are briefly:
1) that all responses are controlled by two mutually
antagonistic neurochemical systems, 2) that one system
is cholinergic and tends to inhibit unrewarded responses
while the other is adrenergic and tends to increase the
probability of occurence of rewarded responses, 3) that
the adrenergic control system can be activated by fear
or conflict situations and finally, 4) the two systems
operate in phases, during acquisition the inhibitory
system is dominant, while during performance the adrenergic
system is in control of behavior.
The model itself is a direct application of the
19
combined Carlton-Gerbrandt model outlined above to behavior
fixations. Now, one can examine the Maier paradigm to see
if the above assumptions can explain the development of a
fixation. During training the animal has built up equal
excitation to all four stimuli in both directions (spatial
right versus left; light cue - bright versus dark) due to
the fact that all stimuli were rewarded equally. Therefore
the animal comes into the initial task relatively unbiased
and can make responses to each stimulus.
Then the animal is put into the insoluble problem
stage. A new dimension enters the situation at this point
in that negative incentives are operative. If the animal
jumps to the incorrect window, he falls four feet and if
he delays jumping for over 30 seconds, he receives a
painful shock. Negative incentives create two types of
activity according to our assumptions. First, whenever
the animal jumps to the incorrect window, the inhibitory
(I) system for that response becomes more active and
inhibits all excitation for that response pattern.
Concurrently, the fear that is aroused by the fall and
shocks received by the animal increases the adrenergic
excitatory activity in all response systems. This
increased adrenergic activity, however, affects activity
only in the non-punished response systems for, although
norepinephrine is released in the response system that
controlled the punished response, it does not lead to more
20
activity due to the active inhibition of the I system.
Therefore, on the next jump, the animal is less likely to
make the previous punished response. If punished to the
right bright the animal might now jump to left bright
because the I system to right might be high and the
adrenergic system (E system) to left has been increased
by fear. In a normal soluble situation, the animal would
thus alternate his responses depending on the contingencies
of reward and punishment. A punished response would be
inhibited by I system while unpunished responses would
benefit from more adrenergic activity due to fear and the
increased activity from reward. Thus, eventually the animal
would build up excitation to the correct response. Further,
when the I system phased out later in acquisition, the
total excitation for the correct response would be much
higher than competing responses; the correct response
would be "released" on every trial and the animal would
solve. Finally, it is proposed that these events occur
with one dimension at a time (spatial or non-spatial).
After one dimension is equally punished and inhibited,
the animal switches to the other dimension. This dimension
is then under the control of the I and E systems and the
correct response is thus strengthened differentially.
This is the process that leads to solutions in the
soluble problem.
In the insoluble problem, however, there is no correct
response since all the responses are punished randomly, and
21
ultimately, inhibition and excitation build up evenly for
all responses. Therefore, the animal during acquisition
may alternate its responses trying to improve its situation.
Somehwere during acquisition, the organism must find an '
equilibrium for all these systems since both E and I
cannot build up indefinitely. Therefore, the built-in
safety factor labeled by Gerbrandt (1965) as the I system
"phase-out" occurs to stop this buildup. (The animal now
has high E and I systems depending on what response was
punished least.) At any given time one system is more
dominant than any of the others (i.e., the system that
was rewarded most). When the I system phases out it does
so quickly within one or two trials thus leaving one
response in one dimension (remember only one dimension
is handled at a time) dominant. The systems are now "set"
and an equilibrium is reached where negative incentives
no longer effect the buildup of these systems. The I
system is phased out and thus not excited. The fear
associated with falling and shock merely maintains
excitation at these "set" levels thus offsetting any
decay over time that might occur. Under this mechanism
the animal has reached a type of physiological equilibrium
which in psychological terms might be termed "a reduction
of conflict". The animal will remain fixated in this
response pattern until the external stimuli change
significantly to allow the animal to recognize a change
in reward contingencies and thus cause the I system to
22
phase in again to begin the process of extinction which
always precedes the acquisition of a new learned response.
In essence, the animal has to some extent treated the
insoluble problem as soluble, phasing out his I system, so
that he can settle down to one response pattern. The only
difference is that the response he choses is not rewarded
100^ of the time.
In the soluble problem, the animal soon learns that a
new problem is present. Typically the animals show a
distinct latency curve separation to the correct and
incorrect stimuli, jumping faster to the correct than to
the incorrect window (Feldman and Green, 1967). This
information (i.e., the discrimination) is relayed to the
performance systems and the I system becomes active again.
In 15 to 20% of the animals tested the I system actually
is strong enough to overcome the excitation of the dominant
response and extinction takes place. The fixated response
is inhibited and excitation quickly builds up to the
rewarded response and allows the animal to solve. In
regard to solutions, it is suspected that this small
percentage of animals are those that Krech et al. (1956)
noted had higher levels of ChE and thus more active I
systems. These are the animals, it may be recalled, who
were able to shift dimensions more readily and were less
under the control of the dominant stimulus. These are the
animals who can inhibit a response to the dominant stimulus
and act in a more probabilistic manner to obtain reward.
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In regard to the ability of an animal to show quick
solutions after the initial "breaking" jump (i.e., the
animals do not show typical learning in the Maier paradigm;
after the first correct jump to the non-fixated side they
usually continue to solve with few errors [Feldman and
Green, 1967] ), the following must be stressed. The 1
and E systems so far discussed are considered performance
systems and can control behavior in the above manner only
when other centers make the association between reward
contingencies and stimuli. Therefore, an animal that does
not show latency differences to bright and dark in the
soluble problem cannot act according to the model and
solve. In this case, all stimuli are equally punishing
so no consistent pattern of inhibition can occur. Thus,
reward contingencies must be evaluated before the
performance systems can play an important role in
controlling behavior.
Now that the model has been applied to solvers what
about the other of the animals who do show latency
differences (i.e., do appreciate the reward contingencies)
but who do not solve? In these cases, either the E system
has become so dominant due to fear that the inhibitory
system Is unable to suppress it; or what is more likely,
these animals because of genetic and/or environmental
deficiencies have less ChE levels in these systems thus
reducing the activity in their I system. These animals
are unable to inhibit the response to the dominant stimulus
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and continue their fixated behavior patterns.
In summary, fixation takes place when no solution can
be found by the animal to stabilize the upward trend of
excitation in the response systems. When no clearly
dominant response (i.e., reward response) can be found,
the animal makes one by the normal "phasing out" of the I
system. This "phasing out" sets the excitation levels of
the response so that one is dominant. Therefore, one
response becomes fixated even if it is not "correct",
in order to stabilize the response systems involved.
Before predictions from the above model are made, one
point requires clarification. The only known method of
breaking behavior fixations is to guide the animal to the
correct window, thus "forcing" the animal to make the
correct choice for several trials. After this treatment,
the animals when given a free choice will solve (Maier,
19^9)* The above model explains this data in the followin
manner. Animals forced to go to the correct window (dark)
on the non-fixated side undergo two basic changes. First
the E system to this window is built up because this
response is rewarded (i.e., by food). Secondly, and more
importantly, the behavioral conditions are radically
altered from that of the normal condition. The animal
becomes aware that the problem has changed in that the
stimuli are different (a plexiglas screen is used) and
the reward contingencies are different (100 vs 50$ reward)
This realization causes the I system to be triggered into
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activity rapidly and more forcefully than in the normal
transition from insoluble to soluble problem in the Maier
paradigm where the reward contingencies become strengthened
only gradually. Therefore, increased I activity causes
extinction of the fixated response to take place and with
the increased activity of the E system on the non-fixated
side, the animal is able to solve.
The predictions offered in this paper will stem from
a simple 2x2 design where fixated animals are given 10
trials of guidance on the first day and 10 free or
non-guided trials on the second day. For each drug tested
there will be four groups: (1) No Drug, No Drug (ND-ND)
;
(2) Drug, Drug (D-D); (3) No Drug, Drug (ND-D); and (^1)
Drug, No Drug (D-ND) . The drugs used are scopolamine
hydrobromide (an anticholinergic), pilocarpine nitrate
(a cholinomimetic), scopolamine methylbromide and
chlordiazepoxide (CDP). Although the pharmacological
properties of CDP with respect to the neural transmitters
are relatively unknown, there is some evidence to suggest
that it interferes with adrenergic activity in such a
way as to reduce it. Scheckel and Boff (1966) reported
that diazepam (similar in structure to CDP) can block
the behavioral stimulation usually recorded with increases
in adrenergic activity caused by injections of tetrabenazi
and oproniazid. Therefore, for our purposes, CDP ' s action
will be assumed to reduce central adrenergic activity.
The predictions based on the above hypotheses are
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as follows:
(1) CDP when given to fixated animals in the
above 2 x 2 design will generally have a detrimental
effect on solutions. This is because the E system
associated with the response to the non-fixated side
will not build up as fast as normally expected under
guidance due to the presumed anti-adrenergic effects
of CDP. Specifically, since the free day is the
time when this adrenergic system is needed most
(i.e., fear to the negative incentives builds up E
system to the non-fixated response), the D-D and ND-D
groups will perform the worst when compared to the
control. The D-ND group should show a slight
decrement when compared to the ND-ND control since
adrenergic feedback from reward on the guided day
will be reduced.
(2) Pilocarpine, since it is a cholinomimetic,
will generally enhance the ability of animals to
solve. Since it increases the I system, and since
this system is most active on the free day, the D-D
and ND-D groups will perform the best when compared
to the control. The D-ND group should not be
significantly different from the control.
(3) Scopolamine, since it is an anticholinergic
drug, will generally be detrimental to solutions.
Specifically, since the I system is needed most on
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the free day, the D-D and ND-D groups will perform
the worst. The D-ND group should not he significantly
different from the control.
METHOD
Subjects
Ss were 78 male albino rats from the colony maintained
by the University of Massachusetts Psychology Department •
(descendants of Charles River CD stock). Ss ranged in
ages from 4 months to 1 year at the beginning of the
study. All rats were fed approximately 40 gm per day of
moist Purina Lab Chow and were allowed free access to water
in their living cages. 27 rats were trained by E to
produce fixations by the method described below. 51 rats
were trained by other experimenters in the same way and
came from other experiments which made use of insoluble-
soluble problem sequences and resulted in behavior
fixations. Of these 51 animals, 30 were distributed in
the chlordiazepoxide (CDP) procedures, and the other 21
were distributed in the scopolamine and pilocarpine
procedures. The 27 rats trained by E were distributed
in the pilocarpine and scopolamine series only. The use
in this experiment of fixated animals from other
experiments assumes that all fixated animals are basically
constant with respect to this variable. Feldman and
Lewis (1962) have shown that fixated rats tested over
121 days (1210 trials) under a variety of conditions never
deviated from their fixated response. This supports the
assumption of the equivalence and the stable characteristics
of fixated animals.
29
Apparatus
The apparatus used was a modified semi-automatically
controlled Lashley jumping stand similar to that described
by Feldman (19^8). This stand essentially consisted of a
platform from which a rat could jump to one of two windows.
One window was dark and the other was illuminated (bright)
by a 25 watt bulb which was situated behind one of the
two opaque plexiglas windows. The position of the bright
or dark window, and the selection of which window was to
be locked was controlled automatically via a switching
apparatus described by Feldman (1948). A correct
response through an unlocked window led to food reward,
and an incorrect response to a locked window led to a
bump and a fall into a net 39 inches below. Response
latency in seconds was measured by starting an electric
timer when the rat was placed on the jumping platform and
stopping it when the rat responded. The platform
consisted of a metal grid through which a shock of .40 ma
(120 v) was delivered to each animal 30 seconds after it
had been placed on the stand if the S had not yet jumped.
A dish of food was available on the platform behind the
windows as reward for correct responses.
Procedure
27 Ss were trained to jump by a method of approximation.
At first the _Ss were placed on the feeding platform with
their daily food ration. After three or four days of
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familiarization with the apparatus, S_s were given
individual training trials. During this period the
jumping platform was placed close to the stimulus windows
which were held in an open position, and the rats were
required to step through them to the platform behind the
windows where food was available. In order to prevent
position habits, each S> was manually guided on even-
numbered trials to the window opposite the one it had
chosen on the previous trial. Each rat received 10 trials
a day, 5 jumps to each window. Every day the jumping
platform was moved back about one inch from the windows
until the rats were jumping 8 1/2 inches. Then, the
windows were gradually closed. At first the rats had
to brush past them, but eventually they had to push them
open in order to reach the food reward on the back of the
platform. One of the windows was illuminated, thus
presenting the rat with a bright-dark stimulus pattern.
The bright and dark windows were switched after every
even-numbered trial. The guidance on even-numbered trials
continued throughout this training period. The rats were
fed during jumping trials and were allowed to finish
their daily ration in a 1/2 hour period immediately
following their jumping trials.
After preliminary training, each S_ was given the
insoluble problem situation for 160 trials at 10 trials
per day. In the insoluble problem situation, the windows
were locked in random order so that there was no response
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which permitted consistent escape from punishment (i.e.,
each animal was punished 50$ of the time in a random order).
The rats soon showed increased resistance to jumping and
the grid shock was necessary to force a response 30 seconds
after the trial began. After about 40 or 50 trials the
animals showed a consistent response pattern, always
jumping to the right, left, bright, or dark windov/. The
position stereotype was the dominant mode of response and
most animals jumped either to the right or left consistently
Sixteen days were set as the limit for this phase since
Maier and Feldman (19^8) found that the optimum number of
fixations and the optimum strength of fixations could be
obtained with about 160 trials.
Following the insoluble problem phase, all the rats
were given a 20-day test, 10 trials per day, for the
stability of their responses. A 20 day test period was
chosen because Maier, Glaser, and Klee (19^0) have
shown that if the rat changes its stereotyped response,
for a new one, it will probably do so within 200 trials.
The soluble discrimination situation used in this phase
consisted of requiring each rat to abandon its
stereotyped response for a learned bright-dark
discrimination. Animals that had developed left or right
position responses, or consistent response to the bright
window, were now required to go to the dark window,
while
those that had developed responses to the dark
window in
the insoluble stage were required to go to the
bright
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window. Animals that solved the discrimination within
the 200 trial test period were dropped from further
experimentation. The criterion of solution was no more
than one error in three successive days (i.e., one mistake
In 30 consecutive trials).
All animals whose stereotyped responses persisted
after the ?0 day tost for fixation, and the animalr.
that came from other experiments, 78 animals in all, were
divided into 1] groups. These group;; fol.'l into throe
categories as follows: (1) the chlordiazepoxidc; (GDP)
groups which consisted of 30 animals from other experiment;;;
(?) the pilocarpine groups which consisted of 13 Ss
trained by the E and 7 Ss from other experiments, and,
(3) the scopolamine groups which consisted of 14 Ss
trained by E and Ik Ss from other experiments.
All fixated animals were given the following treatment.
On the first day each animal was given 10 guided trials
to the correct window of a soluble problem. Guidance
was given by placing a plexiglas screen between the
platform and the incorrect window, thus forcing the animal
to make a correct response. On the next, or even, day
the plexiglas screen was removed and the animals were
given 10 "free" trials during which they could jump to
either window. The third day repeated the sequence with
10 guided trials and so on. In other words, the animals
were guided on odd days and non-guided on all even days.
This procedure wan continued for all animals until they
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solved the discrimination problem on even days or had been
given 340 trials in all, whichever came first. The
criterion for solution was the same as in the soluble
problem; namely, 29 out of 30 correct responses on three
consecutive non-guided days. The motivational factors were
also constant, food being available behind the correct
window, and shock was used if the animal failed to jump
30 seconds after a trial began.
As part of this above treatment, the effects of three
drugs upon problem solutions were tested. Drugs were
administered by intraperitoneal injection. There were four
groups in the CDP series. The first group (ND-ND) consisted
of 9 animals and underwent the above behavioral test with
no drug on either day. The second group (D-D, N=6)
received 15 mg/kg of CDP 30 minutes before the first trial
on both the guided and non-guided days. The third group
(D-ND, N=9) received the drug only on the guided day and
the fourth group (ND-D, N=6) received drug only on the
non-guided day.
In the scopolamine series, S_s received 1.0 mg/kg of
scopolamine hydrobromide 30 minutes before the first
trial on drug days. The first group (D-D, N=7) received
this drug on both days. The second group (D-ND, N=7)
received the drug only on the guided day and the third
group (ND-D, N=7) received the drug only on the non-guided
day. To test for the possible peripheral effects of this
drug, scopolamine methobromide (1.0 mg/kg given 30 minutes
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before the first trial) was given to a fourth group
(N=7). This drug was given in a manner similar to whichever
scopolamine hydrobromide group differed the most from the
ND-ND control group described above in the CDP series.
This group turned out to be the D-ND group and so the
scopolamine methobromide (Methyl- scopolamine ) group received
the drug only on the guided day.
Finally, the pilocarpine nitrate series consisted of
three groups who received 5»0 mg/kg of the drug 30 minutes
before the first trial on drug days. The first group
(D-D, N=7) received the drug on both days. The second
group (D-ND, N=7) received the drug only on the guided day,
while the third group (ND-D, N=6) received the drug only
on the non-guided day.
All animals were run 23 hours food deprived as during
the soluble test described above, and were fed 40 grams
of wet Purina Lab Chow each day after the 10 trials were
completed
.
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TABLE I
Hartley's Test for Homogeneity of Variance
Comparison F Max Value Degrees of Probability
Freedom Value
Overall test
consisting of
all 11 groups 87.42 11, 6 p<.01
CDP Groups 24.85 4, 6 p<.01
Pilocarpine
Groups 77.87 4, 6 p<.01
Scopolamine
Groups 29.97 5, 6 p< .01
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TABLE II
Mann Witney U Values for the Multiple Comparisons
Drug Comparison Mann Witney
U Value
No N-,
1
Probabil
Level
i "Lv
CDP
ND-ND vs D-D 19 9 6 P>.05 ns*
D-ND vs D-D 12 9 6 p <.05 s*
D-ND vs ND-D 13 9 7 p>.05 ns
Scopolamine
ND-ND vs D-D 20 9 7 p>.05 ns
ND-D vs D-D 18 7 7 P >.05 ns
ND-ND vs ND-D 13.5 9 7 P <.05 s
ND-D vs D-ND 17.5 7 7 P>.05 ns
ND-ND vs Methyl-S 28.5 9 7 P >.05 ns
D-D vs D-ND 11.5 7 7 p>.05 ns
ND-ND vs D-ND 5.0 9 7 p < .01 s
Pilocarpine
ND-ND vs D-ND .5 9 7 p < .001 s
ND-ND vs D-D 7.0 9 7 p < .01 s
ND-ND vs ND-D 20.5 9 6 p>.05 ns
ND-D vs D-ND 6.5 7 6 p < .026 s
D-D vs ND-D 18.
5
7 6 P>.05 ns
ns = not significant; s = significant
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for the specific comparison among groups for the three
types of drugs. As can be seen from the table, there
was a significant difference between the D-ND and the D-D
groups in the CDP tests, and a comparison between the D-ND
and ND-D groups showed there was a strong trend toward a
difference. If the U value had been one point less, the
difference would have reached the .05 confidence level.
To summarize, the only significant difference in Figure 1
occurred between the D-D and the D-ND groups, and there
was a strong suggestion that there was a difference
between the D-ND and the ND-D groups.
Scopolamine
Figure 2 presents the percent correct responses as
a function of the number of non-guided days for the three
scopolamine groups, a Methyl-scopolamine D-ND group, and
the ND-ND control. In general, the scopolamine groups
showed a decrement in performance as compared to the
ND-ND control. Table 2 also presents the Mann Witney U
values for the specific comparison among the scopolamine
groups. As can be seen, the only significant differences
were between the ND-ND and ND-D groups and between the
ND-ND and D-ND groups. All other comparisons were not
significant. Both the Methyl-scopolamine and D-D groups
were not significant from the ND-ND control. Furthermore,
the ND-D and the D-ND groups were not significantly
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different. Finally, the other comparisons in Table 2
show that the D-D group was somewhere between the ND-ND
control and the two alternating drug groups (ND-D, D-ND)
and was not significantly different from any of them. In
summary, the only significant difference in Figure 2 was
between the ND-ND control and the two alternating drug
groups (D-ND, ND-D)
.
Pilocarpine
Figure 3 presents the percent correct responses as a
function of the non-guided days for the three pilocarpine
groups and the ND-ND control. This data shows a mixed
effect with some groups doing better than the control and
some worse. Table 2, again, presents the Mann Witney U
values for the specific comparisons. This analysis showed
that both the D-D and D-ND groups in Figure 3 differed
significantly from the ND-ND control. Furthermore, the
ND-D group seemed to lie between the D-D and ND-ND groups
and did not differ significantly from either of them.
Finally, the two alternating drug groups (ND-D, D-ND)
differed significantly from each other. In summary, both
the D-D and D-ND groups differed significantly from the
ND-ND control in Figure 3. The ND-D group did not differ
from the control but it was different from the D-ND
group
.
Comparisons were made, using the Mann Witney U test,
between those animals trained by the E (younger S_s) and
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those that came from other experiments (older Ss). These
comparisons were made within a specific group and therefore
only those groups consisting of both types of Ss could be
used in this analysis. Table 3 presents the Mann Witney U
values for these comparisons. As can be seen, none of
the differences reached a probability level of
.05 and,
therefore, the null hypothesis was not rejected. All Ss
performed consistently within a group, no matter how old
they were or by whom they were trained.
Response Latency
The latency data for all 11 groups was examined
throughout the experiment for non-guided days only. The
data, since many Ss solved, represented a decreasing N.
In some instances, the group latency data consisted of
measures from only one or two animals. For this reason our
curves could only be suggestive and are not presented here.
Table 4 presents the mean latencies for the first non-guided
day for the six alternating drug condition groups. These
latencies gave the impression the CDP lowered mean latency
while scopolamine and pilocarpine raised them. Therefore,
in this context, pilocarpine and scopolamine would seem to
have the same behavioral effect.
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TABLE III
Mann Witney U Values for Groups with
Differentially Trained Ss
Pilocarpine
Scopolamine
Drug Comparison Mann Witney Np N-. ProbabilityU Value 1 Level
D-D 4.5 5 2 p = .571
ND-D 1.0 3 3 P - .10
D-ND 3 52 p = .286
D-D 5 5 2 p = .571
ND-D 3 5 2 p = .286
D-ND 5 4 3 p = .429
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TABLE IV
Latency Data for the First Non-Guided Day
for the Partial Drug Groups
CDP ND-D 15.08 sec
CDP D-ND 18.11 sec
Scopolamine ND-D 26.58 sec
Scopolamine D-ND 14.24 sec
Pilocarpine ND-D 26.10 sec
Pilocarpine D-ND 12. 63 sec
Groups Latency Difference Between
Groups
3.03 sec
+12.34 sec
+13.47 sec
DISCUSSION
It was predicted that the drugs used would have their
effects, either detrimental or enhancing, on the non-guided
day in particular, and so the groups that would differ
significantly from the control would be the D-D and ND-D
groups. In almost all cases, however, the two alternated
drug groups (D-ND and ND-D) performed worse than either the
ND-ND control or the D-D group given the same type of drug
on both days
.
An explanation of the separation of performance
curves between the alternated drug groups and the constant
groups (D-D, ND-ND) might be the following. In the ND-ND
and D-D groups transfer from one condition, guided, to the
other, non-guided, was not hindered by a change in stimulus
conditions. That is to say, that the drug or no drug
stimuli were identical on both days. In the alternated
drug groups (D-ND, ND-D), however, these conditions were
not constant. In one case the drug was absent on the
non-guided day and in the other it was present only on
this day.
If this drug-induced decrement was a general effect,
it accounts for some of the discrepency between our former
predictions and the data. Specifically, correct responses
were effected by two contributing factors. These factors
were (1) a general drug induced decrement that separates
the two constant stimuli groups (ND-ND, D-D) and the two
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alternated stimulus groups (ND-D, D-ND) and (2) a specific
drug effect which may have been detrimental or enhancing.
These two factors now allow us to more fully understand
some of the data.
The CDP data (Figure 1) showed that there was a
difference between the alternated condition groups
(D-ND, ND-D) and the constant condition groups (D-D, ND-ND)
.
This difference probably was due to a drug-induced decrement
like the one proposed above. All other differences in
Figure 1 are not significant although the comparison
between the D-ND and ND-D groups did show a strong trend.
The meaning of this trend is in doubt, however, for if it
is interpreted to mean that CDP has a detrimental effect
on the non-guided day (as predicted earlier) then one would
expect that the D-D group would also show a decrement
when compared to the ND-ND control. Since this was not
the case, it seems more parsimonious to assume that this
trend was only due to chance variation or some uncontrolled
variable rather than a specific drug decrement on the
non-guided day. In summary, then, the major finding of
the CDP series was a general drug induced decrement
between the constant condition groups (ND-ND, D-D) and
the alternated drug groups (ND-D, D-ND). No specific
drug effects seemed to be present and thus the predictions
given in the introduction concerning CDP were not borne
out
.
Turning to the scopolamine data in Figure 2, one can
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see that scopolamine, in general, had a detrimental effect
upon performance. Again, the decrement between the two
constant condition groups (ND-ND, D-D) and the two
alternated drug groups (ND-D, D-ND) can be accounted for
by a general drug-induced decrement. This, as in the CDP
series, was the major finding. It accounts for the only
statistical difference in the data. This data, however,
was not very clear cut in that the D-D group seemed to
lie between two groups (ND-ND, ND-D) that were significantly
different from each other. Therefore, the D-D group
could belong to either population. If the D-D group, in
reality, was more closely related to the ND-D group, then
one could argue that scopolamine has a decremental effect
when given on the non-guided day. Furthermore, if this
hypothesis were correct, one would expect that the ND-D
group would perform at a significantly poorer rate than
the D-ND group. This was not so, as Figure 2 readily
points out, and the difference between the D-D and ND-ND
groups was not significant. Therefore, there was little
or no data to support the prediction that scopolamine
would have a specific detrimental effect if given on
the non- guided day.
There was some evidence that the general drug induced
decrement described above was a central effect. The
Methyl-scopolamine control and the ND-ND control did not
differ from each other significantly. This fact argues
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for the central mediation of the behavioral effects of
scopolamine hydrobromide
, since Methyl-scopolamine mimics
the peripheral effects of this drug but does not readily
pass the blood brain barrier (Carlton, 1963).
In summary, the scopolamine series was not clear
cut in its effects. There was a definite general drug
induced decrement as in the CDP series. There was also
some suggestion that there might be a slight specific
decremental drug effect, but this conclusion was rather
tenuous due to the absence of statistical verification.
The pilocarpine data, on the other hand, was much
more clear cut than the other two drug tests. This data
seemed to embody two effects. First, there was some
evidence for a general drug induced decrement in that the
D-ND group differed from the ND-ND control. The fact that
the ND-D group did not differ from the control either
argues against a general drug induced decrement or suggests
that another antagonistic (i.e., enhancing) effect was
connected with this particular group. Since the first two
drug series showed the generalized drug induced decrement,
it would seem that the latter explanation has more
empirical support. If, then, one accepted the hypothesis
that pilocarpine had a specific enhancing effect when
given on the non-guided day, one would expect that the D-D
group would show better performance than the control.
This indeed was the case as seen in Table 2. Therefore,
in this case, specific drug effects were clearly shown
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by the performance of the D-D group. Also, this effect
was enhancing in that it seemed to aid performance and even
counteracted the normal drug induced decrement that usually
occurs between the ND-ND control and the ND-D group.
Furthermore, one can assume that this enhancing effect was
produced only when the drug was given on the non-guided
day. This hypothesis was supported by the poor performance
of the D-ND group.
Therefore, the original hypothesis concerning the
effects of pilocarpine was partially borne out. The
specific effect of the drug was enhancing and was effective
on the non-guided day. The prediction, however, did not
account for the poor performance of the D-ND group.
Furthermore, whether this specific drug effect was due to
pilocarpine's cholinomimetic properties is still in doubt
due to the inconclusive scopolamine data. If the
cholinergic properties of these drugs was crucial one
would expect that scopolamine would have opposite effects
to those seen under pilocarpine. Specifically, the D-D
and ND-D scopolamine groups should show a decrement when
compared to the ND-ND control. This was not the case.
Furthermore, the ND-D scopolamine group should show a
decrement when compared to the D-ND group. Again, this
was not borne out in the data. Therefore, one can only
conclude that the enhancing effects of pilocarpine may
be due to some other properties of this drug and that
its cholinomimetic characteristics did not seem to be
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crucial to the behavioral changes it affected.
In summary, it can be said that the major finding of
this study was the general drug-induced decrement noted
with all three drugs. The secondary finding was the
enhancement effect shown with pilocarpine when it was
administered on the free day. An explanation of this
finding is difficult at the present time due to the
scopolamine data which argues against a cholinergic mechanism.
In the future behavioral measures should be devised that
would reduce the variability that occurred in this data.
The group mean differences in the scopolamine and CDP
series were obscured statistically by the large variances
within groups (i.e., as shown in Table 1). Therefore,
any small specific effects that occurred in either the
CDP or scopolamine series were lost. These variances
might be reduced if a simpler behavioral test was used
(i.e., simple active avoidance) or if other designs using
the Lashley jumping stand were used. Specifically, the
drugs could be given during the insoluble problem to see
if they effect the number of solutions in the soluble
problem. In this design, the data would consist of
a number of solutions and the variances within a group
would no longer be a problem, as it was in the above
design.
SUMMARY
A group of male albino rats from the colony maintained
by the University of Massachusetts Psychology Department
were used in this study. The apparatus consisted of an
adaptation of the Lashley jumping stand which contained an
electrified jumping platform. All animals used in this
study were trained and then subjected to an insoluble,
followed by a soluble problem. 78 of these animals who
failed to solve the soluble problem were then used in the
following 2x2 design. Animals were guided to the correct
window on the first day and non-guided on the second. This
procedure continued until the animals reached a criterion
of 29 out of 30 correct responses on three consecutive
non-guided days or a total of 3^0 trials in all, whichever
came first. There were 11 groups in all and four different
drugs were tested. They were pilocarpine nitrate (5.0
mg/kg), scopolamine hydrobromide (1.0 mg/kg), scopolamine
methobromide (1.0 mg/kg) and chlorodiazepoxide (CDP)
(15.0 mg/kg). The four CDP groups received the drug in
the following order: ND-ND, D-D, ND-D, and D-ND. The
three pilocarpine nitrate groups received the drug in
the following order: D-D, ND-D, D-ND. Furthermore, the
three scopolamine hydrobromide groups received the drug
in an identical order to that of pilocarpine. Finally,
the scopolamine methobromide control received the drug
only on the guided day. The results showed that both
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CDP and scopolamine hydrobromide had detrimental effects
while the pilocarpine nitrate had mixed effects.
The data supported a general drug induced decrement
hypothesis. Furthermore, pilocarpine seemed to have a
specific enhancing effect along with a generalized
decrement. The cause of this specific effect was unknown,
although its cholinomimetic properties seemed not to be
crucial.
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